KRYS - Krystal Biotech reports Q4 results
Krystal Biotech (KRYS): Q4 GAAP EPS of $0.53 beats by $0.05.Cash, cash equivalents and short-term investments of $271.3MPress Release
For further details see:
Krystal Biotech reports Q4 resultsLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
Get KRYS Alerts
News, Short Squeeze, Breakout and More Instantly...